The Future of Gut Health is Personalized: myota’s Patented Prebiotic Fibre Blend

This is an AI generated illustration and does not represent actual product or service.

In the burgeoning world of gut health supplements, it’s rare to find a product backed by rigorous, peer-reviewed science and a granted patent. Most rely on generic ingredient lists and vague promises. However, a new standard is being set by myota, a company founded by scientists whose groundbreaking research has culminated in the first patented prebiotic fibre mix, clinically proven to benefit a wide range of individuals by working in harmony with their unique gut microbiome.

The Core Problem: A One-Size-Fits-All Approach Doesn't Work

Our gut microbiomes are as unique as our fingerprints. The trillions of bacteria residing in our intestines have varying abilities to ferment different types of dietary fibre. This fermentation process is crucial because it produces Short-Chain Fatty Acids (SCFAs)—notably butyrate, propionate, and acetate—which are powerhouse metabolites responsible for most of the health benefits associated with fibre.

The fundamental flaw in many existing fibre supplements is that they contain only one or two types of fibre. If an individual's gut microbiome lacks the specific bacteria to ferment those fibres, the supplement will pass through with minimal benefit, often causing bloating and discomfort instead.

The myota Solution: A "One-Fits-All" Scientific Masterpiece

The inventors at myota identified this critical gap. Through extensive ex vivo fermentation experiments on stool samples from a diverse pool of volunteers, they analyzed how different gut microbiomes fermented a wide array of isolated fibres. Their goal was not to find a single "best" fibre, but to identify a combination that would ensure high production of beneficial SCFAs across the widest possible variety of individual microbiome profiles.

The result is a patented dietary fibre composition detailed in the international patent WO2024115691A1. The core, mandatory mixture consists of six precisely selected, isolated fibres:

1. Isolated Fructo-oligosaccharides (FOS)

2. Isolated Inulin

3. Isolated Resistant Maltodextrin

4. Isolated Resistant Dextrin

5. Isolated Galactomannan Polysaccharide (e.g., Guar Gum)

6. Isolated Partially Hydrolysed Galactomannan (e.g., Partially Hydrolysed Guar Gum)

This combination is strategic. For instance, while FOS and Inulin are both excellent butyrate producers, their different chain lengths are fermented by different bacterial strains, broadening the supplement's efficacy. Resistant Maltodextrin and Dextrin were chosen for their consistent fermentation with low inter-individual variability. The galactomannan fibres were identified as top-tier producers of propionate.

The Three Patented Formulations

The patent provides specific, optimized formulations for three distinct blends, each tailored for different health goals:

• Composition 1 (Immunity Booster): Designed as a pure, high-potency fermentable fibre mix, it contains 33.2% FOS, 25.9% Inulin, 13.8% Resistant Maltodextrin, 11.9% Partially-Hydrolysed Guar Gum, 11.1% Resistant Dextrin, and 4.1% Guar Gum. It contains no insoluble fibres or Galacto-oligosaccharides (GOS) to avoid potential triggers for inflammation, making it ideal for individuals with conditions like IBD.

• Composition 2 (Metabolic Booster): This is the clinically tested blend. It combines the patented soluble fibres (14% FOS, 11% Inulin, 5.8% Resistant Maltodextrin, 5% PHGG, 4.7% Resistant Dextrin, 1.7% Guar Gum) with 13.8% GOS and insoluble fibres (26% Wheat Fibre and 18% Oat Fibre) to provide a comprehensive metabolic regulator that also delivers established EFSA health claims.

• Composition 3 (Mental Wellness): Designed to leverage the gut-brain axis, this blend mirrors the insoluble fibre content of Composition 2 (26% Wheat Fibre, 18% Oat Fibre) but omits GOS to avoid potential irritability. Its fermentable profile is adjusted to 18.6% FOS, 14.5% Inulin, 7.7% Resistant Maltodextrin, 6.7% PHGG, 6.2% Resistant Dextrin, and 2.3% Guar Gum.

Clinically Proven Benefits Beyond Digestion

What sets myota apart is its commitment to clinical validation. The patent document references several trials demonstrating the efficacy of their blends:

• Metabolic Health: A 16-week study on pre-diabetic individuals showed that consuming 20g per day of their metabolic blend (Composition 2) led to significant improvements in insulin sensitivity, reductions in fasting blood insulin, and lower HbA1c (a key marker for long-term blood sugar control) in a key subgroup.

• Microbiome Diversity: Real-world data from customers showed a significant increase in both the diversity and richness of gut bacteria in those who consumed the myota blend compared to those who did not.

• Mental Well-being & GI Symptoms: A 12-week study found that participants taking the myota blend reported significantly greater reductions in perceived stress scores and gastrointestinal symptoms compared to a control group.

Conclusion: A New Era for Fibre Supplements

The myota patent represents a paradigm shift in nutritional science. It moves beyond simply listing beneficial ingredients to designing a synergistic system based on a deep understanding of human microbial ecology. By creating specific, optimized fibre mixes that are deliberately tailored to be fermented by diverse microbiota, myota ensures that a broad population can reliably produce the SCFAs essential for health.

This isn't just another gut health supplement; it is a precision-engineered nutritional tool backed by robust patent claims and clinical evidence, offering a scientifically-grounded solution for improving not just digestive health, but also metabolic function, immune response, and mental well-being.

Trending Stories

Latest Stories